Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2012 New\Report
Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2012, provides an overview of the Idiopathic Pulmonary Fibrosis therapeutic pipeline. This report provides information on the therapeutic development for Idiopathic Pulmonary Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Idiopathic Pulmonary Fibrosis. 'Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC...
View full press release